References
- Biradar SV, Patil AR, Sudarsan GV, Pokharkar VB. A comparative study of approaches used to improve solubility of roxithromycin. Powder Technol 2006;169:22–32
- Heimbach T, Fleisher D, Kaddoumi A. Overcoming poor aqueous solubility of drugs for oral delivery. Bio Pharm Aspects 2007;5:157–215
- Sanghavi NM. Ion-exchange resins as matrices for controlled drug release. Indian Drugs 1988;26:27–32
- Irwin WJ, Belaid KA, Alpar HO. Drug-delivery by ion-exchange. Part III: interaction of ester prodrug of propranolol with cationic exchange resins. Drug Dev Ind Pharm 1987;13:2047–2066
- Jeong SH, Park K. Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix. Int J Pharm 2008;361:26–32
- Srikanth MV, Sunil SA, Rao NS, et al. Ion-exchange resins as controlled drug delivery carriers. J Sci Res 2010;2:597–611
- Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004;21:201–230
- Rubino JT. Cosolvents and cosolvency. In: Swarbrick J, Boylan JC, eds. Encyclopedia of pharmaceutical technology. 3rd ed. New York: Marcel Dekker, Inc.; 2007:806–819
- Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2003;18:113–120
- Serajuddin ATM. Salt formation to improve drug solubility. Adv Drug Deliver Rev 2007;59:603–616
- Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliver Rev 2007;59:645–666
- Vyas A, Saraf S. Cyclodextrin based novel drug delivery systems. J Incl Phenom Macrocycl Chem 2008;62:23–42
- Miyoshi N, Wakao Y, Tomono S, et al. The enhancement of the oral bioavailability of γ-tocotrienol in mice by γ-cyclodextrin inclusion. J Nutr Biochem 2011;22:1121–1126
- Muraoka A, Tokumura T, Machida Y. Evaluation of the bioavailability of flurbiprofen and its β-cyclodextrin inclusion complex in four different doses upon oral administration to rats. Eur J Pharm Biopharm 2004;58:667–671
- Terao K, Nakata D, Fukumi H, et al. Enhancement of oral bioavailability of coenzyme Q10 by complexation with γ-cyclodextrin in healthy adults. Nutr Res 2006;26:503–508
- Koç FE, Şenel M. Solubility enhancement of non-steroidal anti-inflammatory drugs (NSAIDs) using polypolypropylene oxide core PAMAM dendrimers. Int J Pharm 2013;451:18–22
- Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum 1965;4:117–212
- Job P. Job's plot analyses for the 2-CG and 3-CG complexes were consistent with 1:1 stoichiometry. Ann Chim 1928;9:113–134
- Kunin R. Ion exchange resins. New York: John Wiley & Sons; 1963
- Luger P, Daneck K, Trummlitz WEG, Wagner K. Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci 1996;4:175–187
- Hilal SH, Karickhoff SW, Carreira LA. Estimation of microscopic, zwitterionic ionization constants, isoelectric point and molecular speciation of organic compounds. Talanta 1999;50:827–840
- Liu R. Water-insoluble drug formulation. London: CRC Press; 2008
- Higuchi T, Kristiansen H. Binding specificities between small organic solutes in aqueous solutions: classification of some solutes onto two groups according to binding tendencies. J Pharm Sci 1970;59:1601–1608
- Waters LJ, Bedford S, Parkes GMB, Mitchell JC. Influence of lipophilicity on drug–cyclodextrin interactions: a calorimetric study. Thermochim Acta 2010;551:102–106
- Obaidat AA, Khanfar RA, Khawam MN. The effect of β-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modeling. J Incl Phenom Macrocycl Chem 2009;63:273–279
- Sinko PJ. Martin's physical pharmacy and pharmaceutical sciences. London: Lippincott Williams & Wilkins; 2011
- Cabaleiro-Lago C, Nilsson M, Valente AJM, et al. NMR diffusometry and conductometry study of the host–guest association between β-cyclodextrin and dodecane 1,12-bis(trimethylammonium bromide). J Colloid Interf Sci 2006;300:782–787
- Mehta SK, Bhasin KK, Dham S. Energetically favorable interactions between diclofenac sodium and cyclodextrin molecules in aqueous media. J Colloid Interf Sci 2008;326:374–381
- Rajendrakumar K, Madhusudan S, Pralhad T. Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat. Eur J Pharm Biopharm 2005;60:39–46
- Clas S, Dalton CR, Hancock BC. Differential scanning calorimetry: applications in drug development. Res Focus 1999;2:311–320
- Aigner Z, Hassan HB, Berkesi O, et al. Thermoanalytical, FTIR and X-ray studies of gemfibrozil-cyclodetrin complexes. J Therm Anal Calorim 2005;81:267–272
- Figueiras A, Carvalho RA, Ribeiro L, et al. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. Eur J Pharm Biopharm 2007;67:531–539
- Yap KL, Liu X, Thenmozhiyal JC, Ho PC. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis. Eur J Pharm Sci 2005;25:49–56
- Samprasit W, Rojanarata T, Akkaramongkolporn P, et al. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex. Drug Dev Ind Pharm 2013;39:1672–1680
- Guo X, Chang RK, Hussain MA. Ion-exchange resins as drug delivery carriers. J Pharm Sci 2009;98:3886–3902
- Sriwongjanya M, Bodmeier R. Entrapment of drug-loaded ion-exchange particles within polymeric microparticles. Int J Pharm 1997;158:29–38